Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). (Q35776186)
Jump to navigation
Jump to search
scientific article published on 29 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). |
scientific article published on 29 January 2015 |
Statements
1 reference
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). (English)
1 reference
Helen Michael
1 reference
Bradley J Monk
1 reference
Richard T Penson
1 reference
Helen Q Huang
1 reference
Lari B Wenzel
1 reference
Sharon Stockman
1 reference
Harry J Long
1 reference
Lois M Ramondetta
1 reference
Lisa M Landrum
1 reference
Ana Oaknin
1 reference
Thomas J A Reid
1 reference
Mario M Leitao
1 reference
Michael Method
1 reference
Krishnansu S Tewari
1 reference
29 January 2015
1 reference
1 reference
16
1 reference
3
1 reference
301-311
1 reference
Identifiers
1 reference
1 reference
1 reference